A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of Infliximab
(Remicade) in patients with Rheumatoid Arthritis. Infliximab (Remicade) targets specific
proteins in the body's immune system to help control the development of inflammation to help
reduce the pain of rheumatoid arthritis.